CATHERINE OBIN: Open Payments
NPI 1841286739 · WAREHAM, MA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$805 in 10 payments from 8 companies in 2025. Trend: 2023 $330 · 2024 $781 · 2025 $805
Food & beverage: $755Long term medical supply or device loan: $50
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 3 | $148 |
| Lilly USA, LLC | 1 | $125 |
| ARS Pharmaceuticals Operations, Inc. | 1 | $120 |
| ABBVIE INC. | 1 | $106 |
| Hologic Sales and Service, LLC | 1 | $101 |
| SANOFI-AVENTIS U.S. LLC | 1 | $84 |
| Calliditas Therapeutics US Inc. | 1 | $71 |
| Abbott Laboratories | 1 | $50 |
Products named: BREZTRI, NEFFY, RINVOQ, APTIMA, TZIELD, TARPEYO, FREESTYLE INSULINX.
Industry payments across MA — which companies pay providers there.
